Celemics, Inc. (KOSDAQ:331920)
9,860.00
-150.00 (-1.50%)
At close: Aug 11, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 110.25 billion as of August 12, 2026. Its market cap has increased by 327.35% in one year.
Market Cap
110.25B
Enterprise Value
104.75B
Revenue
4.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,860.00
ChartMarket Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 110.25B, a decrease of -44.96%. That is a compound annual growth rate of -9.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 110.25B | 397.39% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curiox Biosystems | 708.77B |
| Biodyne | 244.07B |
| M.I.TECH Co.,Ltd | 164.42B |
| BIOBIJOU | 161.73B |
| Synergy Innovation | 147.58B |
| RecensMedical | 118.59B |
| Corentec | 57.52B |
| DENTIS CO.,Ltd | 45.93B |